Strategic partnership Eye-Com’s biosensor and eye-tracking tech has already progressed to Eyefluence, indicating a potential sales opportunity through channel partnerships or acquisition-driven collaborations to expand market reach and accelerate go-to-market.

Healthcare suitability Applications in fatigue detection and assistive communication align with medical devices markets and disability tech, suggesting opportunities to target hospitals, rehabilitation centers, and research institutions for pilots or regulatory-ready devices.

Grants to growth Government grant funding signals validated technology and potential for funded R&D partnerships, which could translate into government procurement programs or grant-backed pilot programs with customers in safety, aviation, or aging populations.

Small but nimble Compact team size (2-10 employees) and mid-range revenue indicate agility and customization capability, making Eye-Com a candidate for high-touch, contract-based deals with tailored features, rapid iterations, and white-glove support.

Tech-enabled sell The move to Eyefluence for continued development points to a strong technology moat; sales strategies can emphasize legacy BIOSENSOR accuracy, eye-tracking performance, and integrability with existing医疗/assistive devices to differentiate from competitors.